Shares in Giant Biogene jumped sharply on the company’s November 4 listing on the Hong Kong stock exchange. The company priced its IPO at HK$24.3 per share and traded as high as HK$31.95 Monday November 7 – an increase of just over 30%. A portfolio company of Legend Capital, Giant Biogene is a leader in…
Home Healthcare Markets International Business Hong Kong: Giant leap in share price for Giant Biogene IPO